Background and Aims: breast reconstruction with silicone prosthesis following nipplesparing mastectomy has become widely accepted as a reconstruction option in women requiring mastectomy for cancer. the purpose of this study was to evaluate the incidence and some factors influencing early local complications in patients undergoing nsm with immediate implant reconstruction.
of women and at the same time does not threat the oncological safety (1, 2, 3).
However, breast reconstructions are subject to possible postoperative complications related either to wound healing or flap viability. This can lead to significantly prolonged convalescent periods in the immediate postmastectomy setting and may delay the initiation of subsequent chemotherapy or radiotherapy. Also, serious complications usually require another surgery with high probability of implant loss. Therefore breast reconstruction demands a skilled oncoplastic surgeon in order to achieve the best cosmetic result, minimize complications and what is the most important perform oncologicaly radical operation.
INTRODuCTION
Breast reconstruction has become a standard of care for almost all women requiring mastectomy for breast cancer. It greatly improves psychological well-being This study presents single institution experience in primary breast reconstruction with implants following nipple-sparing mastectomy (NSM). We focused our analysis firstly on incidence of early surgical complications and secondly to some factors influencing them.
MATERIAlS AND METHODS
From January 2004 till December 2008, 205 consecutive breast cancer patients at the Department of Surgical Oncology, Oncology Institute of Vojvodina, Serbia, undergoing 214 nipple sparing mastectomies followed by immediate breast reconstruction with fixed volume silicone prosthesis were included in this prospective study.
Preoperative diagnosis was obtained with the aid of physical examination, ultrasonography, mammography (MR mammography in some cases) and fine needle aspiration cytology or core biopsy. 39 patients (19%) with locally advanced disease were treated with neoadjuvant chemotherapy (FAC: 5-fluorouracil, doxorubicin, cyclophosphamide; 4 cycles every 3 weeks). Radiotherapy was not used in neoadjuvant setting but all patients with previous breast conserving surgery (BCS) had radiotherapy as part of their adjuvant treatment (27 patients). Before surgery, patients were all counseled on oncological safety of the procedure, risks of early and late complications, benefits and postoperative aestetic expectations. Contraindications to NSM included inflammatory breast cancer, extensive skin involvement by tumor and Paget's disease.
Mastectomy was performed using lateral incision usually extended to upper outer quadrant thereby allowing axillary access. Others type of incisions were used only in cases with previous excisional biopsy or BCS in order to incorporate the previous incision into the NSM incision. In all cases we performed frozen section examination of the subareolar tissue. If there was evidence of cancer cells in the subareolar space, the nipple-areola-complex (NAC) was removed. Patients with tumours under 3 cm and some patients with DCIS had sentinel lymph node biopsy including perioperative frozen section examination. Axillary clearance (levels I and II) was performed if sentinel node biopsy revealed metastases and in all cases of invasive multicentric breast cancers, tumors over 3cm and local recurences after BCS with previously performed sentinel node biopsy. If NSM was performed due to local recurrence after BCS with axillary clearance, staging was assessed according to histopathology of the first operation.
Breast reconstruction was done with gel filled prosthesis (Mentor Contour Profile ® , fixed volume implants) placed under the pectoralis major and serratus anterior muscles. The excised breast tissue is weighed to estimate the size of the prosthesis needed. The muscles were closed with absorbable interrupted suttures while skin was closed with absorbable interrupted suttures in deep dermis and continuous absorbable intradermal suttures. usually two drains were placed. All patients were given three days prophylactic antibiotics.
For this study, postoperative follow-up was six weeks. We recorded all early complications and treatment procedures. Skin necrosis less than 2 cm 2 was recorded as minor while larger area of necrosis was set as major. Infection treated with oral antibiotics was minor while parenteral administration of antibiotics was considered as major infection. Statistical analysis was done with SPSS v.16 using Pearson's chi-squared and Fisher's exact test for subgroups comparison. The level of significance was set at 0.05.
RESulTS
Mean patient age was 47 years (range 26 to 69). unilateral mastectomy was performed in 196 and bilateral mastectomy in 9 women. Mean implant size was 340 ml (range 135-775 ml, median 315 ml). Indications for mastectomy are presented in Table 1 and tumour caracteristics, stage and associated axillary evaluation in Table 2 .
Overall six-week complication rate was 16% (35 procedures) and they are presented in Table 3 . The most common early complication was skin flap and/ or NAC necrosis that occured in 7,5%, 16 procedures (NAC necrosis 2 procedures (1%), major skin flap and NAC necrosis 3 procedures (1,5%), major skin flap necrosis 4 procedures (2%); minor skin necrosis 7 procedures, 3%). They all required surgical reinterven- tion that lead to explantation of prosthesis in 7 cases. Total number of explantations was 12 (6%) in 11 patients (Table 3) . One woman with bilateral reconstruction had major skin necrosis on one side that was reason for explantation and she insisted on the removal of the contralateral implant also. In four cases NAC had to be removed due to positive frozen section analysis of subareolar tissue.
Thirty nine patients received neoadjuvant treatment (42 breast reconstruction procedures). Complication rate in this group of patient was 9%: epidermolysis 2% (one procedure), major skin necrosis 5% (2 procedures) and minor infection 2% (one procedure). In 3 of these cases prosthesis explantation was done (7%). However, no statistically significant relationship between neoadjuvant treatment and early complications or prosthesis removal was noticed (p = 0,24 and p = 0,74, respectively). We also separately analized 27 cases who had NSM due to local recurrence after BCS to see if radiotherapy had any impact on complication rate in this group of patients. 5 patients (18,5%) had complications: major skin necrosis 4% (1 case), major infection 4% (1), minor infection 7% (2) and prolonged seroma formation 4% (1). In 3 cases (11%) implant had to be removed. There is no significant relationship between adjuvant radiotherapy after BCS and early surgical complications following NSM (p = 0,78). using non parametric MannWhitney u test we compared patients with and without complications with their age and implant size and found no statistical difference between these groups (p value for age and implant size was 0,16 and 0,68 respectively).
All operations were performed by 7 general surgeons with different experience in breast oncoplastic techniques. For statistical analysis we divided them into two groups: Group I (two surgeons who performed 68% of operations) and Group II (five surgeons with 32% of operations). Group I had 12% of complications with explantation rate of 3% while Group II had 28% of complications with 13% of prosthesis removal. By comparing results of these two groups of surgeons we found significant difference in complication and explantation rate with p value of 0,03.
DISCuSSION

BREAST RECONSTRuCTION TECHNIquES
Reconstruction after mastectomy can be done by a variety of autologous tissue flaps, prosthetic implants, or their combination. Common techniques of autologous tissue reconstruction are pedicled transverse rectus abdominis myocutaneous flaps (TRAM flap) and microvascular transfer of TRAM, latissimus dorsi myocutaneous flaps, gluteal and lateral transverse thigh flaps (4). If there is inadequate volume, breast implants can be combined with any of these flaps, mostly with the latissimus dorsi flap. Reconstructions using purely autologous tissue are generally believed to allow for superior cosmesis, but are substantially more complex than those using prosthetic material (5). The technique of subcutaneous mastectomy followed by reconstruction was first reported in 1962 by Freeman (6). The term skin-sparing mastectomy (SSM) was introduced by Toth and lappert in 1991 (7) to describe a technique of skin preservation to facilitate breast reconstruction. From that time breast reconstruction has evolved from a rarely performed surgical procedure to a daily occurrence that has become an important part of the rehabilitation process following mastectomy.
Immediate reconstruction with prosthesis is relatively simple one stage procedure with less costs and complications than autologous reconstructions or any kind of secondary (posttreatment) reconstruction (4). We prefer this type of primary breast reconstruction because it can be done by surgical oncologist trained in oncoplastic breast surgery and it is not techically demanding as autologous reconstructions. In all cases prosthesis was placed under the pectoralis major and serratus anterior muscle complex. Subcutaneous implant position is not recomended because of high incidence of flap necrosis, implant malposition, infection and capsular contracture (8,9). 7
EARlY SuRGICAl COMPlICATIONS Rate of complications in implant reconstruction is in 15 to 20% range, most often with skin necrosis or infection as leading complication (4,5,8,10). The differences in complication rate can be explained by variations in surgical technique, types of incision, patient selection criteria, antibiotics and drainage use etc. The most common complication in our study was major skin necrosis. In similar study by Contant et al.
(115 breast reconstructions with a silicone prosthesis) rate of early complications was 15% with infection as leading complication (10) . According to our analysis, factors like patient age, size of implant, neoadjuvant chemotherapy and radiotherapy were not associated with higer rate of complications. However, surgeon experience is very important factor influencing early surgical complications. Comparison of experienced and unexperienced groups of surgeons clearly demonstrates the impact of surgical education and patient volume on complication rate.
In implant reconstruction following NSM the most concerning complication is NAC or skin flap necrosis. It requires another surgery and leads to increased risk of implant loss. As mentioned before, we had necrotic complications in 16 procedures (7,5%). In other published series of NSM, the percentages of patients with necrotic complications varies between 3 and 20%. (10, 11, 12, 13, 14, 15) . Komorowski et al. in a study that included 38 patient with NSM had 15,8% necrotic complications. It is important that in 70% of cases they used periareolar omega-shaped aproach (16) . We beleive that periareolar incisions might jeopardize the blood supply and we prefer lateral incisions. Crowe et al. also suggested that a lateral incision for NSM may contribute to nipple-areola complex viability (13) . Interesting study by Rusby and colleagues (17) on nipple microvessels and their position to lactiferous ducts showed that in an non-irradiated nipple a 2-mm rim of peripheral nipple tissue retains 50% of the vessels of the nipple cross-section, while a 3-mm rim retains 66% of vessels. According to their study, leaving a peripheral rim of 2 mm of nipple skin and subcutaneous tissue resulted in complete excision of the duct bundle in 96% of cases, while a peripheral rim of 3 mm would lead to complete excision in 87%. So surgeon is forced to make compromise between removal of all duct tissue and the preservation of blood vessels to maintain viability of the nipple remnant.
ONCOlOGICAl SAFETY OF NIPPlE-SPARING MASTECTOMY Are we oncologicaly radical in NSM? Gerber et al. after 59 months of follow-up concluded that patients with NSM are not under greater risk of local recurrences compared to patients with modified radical mastectomy or skin-sparing mastectomy (18) . Similar study by Sandelin et al. confirmed this (19) . Nipple involment in histological studies ranges from 0% to as much as 58% depending on the size of the primary breast tumor, location, multicentricity, lymph node positivity, and presence of an extensive intraductal component (11, 20) . In 214 NSM we had five cases with nipple involment (2,33%). The discrepancies between studies concerning nipple involment are largely due to different sample size of study, stage, techniques used for the pathological examination of the specimen and different exclusion criteria. Additional long term follow up studies on NSM will give us answers about oncological safety of the procedure in terms of local recurences (especialy in NAC region) and survival. Till now there is no proof that patients with NSM and reconstruction are at greater risk of local recurrence (1, 14, 19, 21, 22) .
CONCluSION
The aim of modern breast surgery is not only to be oncologicaly radical but also to decrease the psychological trauma to the affected patients. Therefore, immediate implant reconstruction after NSM is valuable option for primary treatment of breast cancer. It has acceptable complication rate in the hand of experienced oncoplastic surgeon and therefore should be offered as treatment option to carefully selected women requiring mastectomy.
